|
gptkbp:instanceOf
|
gptkb:chemical_compound
nerve agent
|
|
gptkbp:antidote
|
gptkb:pralidoxime
atropine
|
|
gptkbp:appearance
|
colorless liquid
|
|
gptkbp:aroma
|
slightly fruity
|
|
gptkbp:boilingPoint
|
230°C
|
|
gptkbp:broadcastOn
|
Schedule 1 (CWC)
|
|
gptkbp:CASNumber
|
329-99-7
|
|
gptkbp:category
|
gptkb:G-series_nerve_agent
|
|
gptkbp:chemicalFormula
|
C7H14FO2P
|
|
gptkbp:countryOfOrigin
|
gptkb:Germany
|
|
gptkbp:density
|
1.09 g/cm³
|
|
gptkbp:developedBy
|
chemical weapon
|
|
gptkbp:firstSynthesized
|
1940s
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cyclosarin
|
|
gptkbp:IUPACName
|
cyclohexyl methylphosphonofluoridate
|
|
gptkbp:mechanismOfAction
|
gptkb:acetylcholinesterase_inhibitor
|
|
gptkbp:meltingPoint
|
-30°C
|
|
gptkbp:molecularWeight
|
180.16 g/mol
|
|
gptkbp:persistenceMechanism
|
more persistent than sarin
|
|
gptkbp:prohibits
|
gptkb:Chemical_Weapons_Convention
|
|
gptkbp:relatedTo
|
gptkb:sarin
soman
|
|
gptkbp:riskFactor
|
causes convulsions and death
|
|
gptkbp:solubility
|
slightly soluble
|
|
gptkbp:storage
|
requires sealed containers
|
|
gptkbp:toxicity
|
highly toxic
|
|
gptkbp:UNNumber
|
N/A (prohibited)
|
|
gptkbp:used_in
|
Iraq (alleged)
|
|
gptkbp:volatility
|
less volatile than sarin
|
|
gptkbp:bfsParent
|
gptkb:G-series_nerve_agent
|
|
gptkbp:bfsLayer
|
8
|